May 30, 2025
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
| Re: | Imunon, Inc. – Resale Registration Statement |
Ladies and Gentlemen,
Attached please find the Registration Statement on Form S-1 filed by Imunon, Inc. (the “Company”) in connection with the secondary offering of shares by certain stockholders of the Company.
If you have any questions or comments regarding this filing, please call me at (330) 819-1221 or contact me via e-mail at Jurgita.Ashley@ThompsonHine.com. We would appreciate if you could please advise us once your review is completed.
| Respectfully, | |
| /s/ Jurgita Ashley | |
| Jurgita Ashley |
| cc: | Susan Eylward, General Counsel and Corporate Secretary of Imunon, Inc. (seylward@imunon.com) |
